Cargando…
Sars-Cov-2 Vaccination Response Monitoring in Lymphoma and Multiple Myeloma Patients Following Standard Versus High-Dose Chemotherapy and Autologous Stem Cell Transplantation
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665176/ http://dx.doi.org/10.1182/blood-2022-166703 |
| _version_ | 1784831232065929216 |
|---|---|
| author | Markovic, Uros Milone, Giulio Antonio Carco, Daniela Iachelli, Valeria Parrinello, Nunziatina Laura Scire, Paola Amato, Gabriella Galbo, Federica Milone, Giuseppe Martorana, Emanuele Moschetti, Gaetano |
| author_facet | Markovic, Uros Milone, Giulio Antonio Carco, Daniela Iachelli, Valeria Parrinello, Nunziatina Laura Scire, Paola Amato, Gabriella Galbo, Federica Milone, Giuseppe Martorana, Emanuele Moschetti, Gaetano |
| author_sort | Markovic, Uros |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9665176 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The American Society of Hematology. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96651762022-11-16 Sars-Cov-2 Vaccination Response Monitoring in Lymphoma and Multiple Myeloma Patients Following Standard Versus High-Dose Chemotherapy and Autologous Stem Cell Transplantation Markovic, Uros Milone, Giulio Antonio Carco, Daniela Iachelli, Valeria Parrinello, Nunziatina Laura Scire, Paola Amato, Gabriella Galbo, Federica Milone, Giuseppe Martorana, Emanuele Moschetti, Gaetano Blood Poster Abstracts The American Society of Hematology. Published by Elsevier Inc. 2022-11-15 2022-11-15 /pmc/articles/PMC9665176/ http://dx.doi.org/10.1182/blood-2022-166703 Text en Copyright © 2022 The American Society of Hematology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Poster Abstracts Markovic, Uros Milone, Giulio Antonio Carco, Daniela Iachelli, Valeria Parrinello, Nunziatina Laura Scire, Paola Amato, Gabriella Galbo, Federica Milone, Giuseppe Martorana, Emanuele Moschetti, Gaetano Sars-Cov-2 Vaccination Response Monitoring in Lymphoma and Multiple Myeloma Patients Following Standard Versus High-Dose Chemotherapy and Autologous Stem Cell Transplantation |
| title | Sars-Cov-2 Vaccination Response Monitoring in Lymphoma and Multiple Myeloma Patients Following Standard Versus High-Dose Chemotherapy and Autologous Stem Cell Transplantation |
| title_full | Sars-Cov-2 Vaccination Response Monitoring in Lymphoma and Multiple Myeloma Patients Following Standard Versus High-Dose Chemotherapy and Autologous Stem Cell Transplantation |
| title_fullStr | Sars-Cov-2 Vaccination Response Monitoring in Lymphoma and Multiple Myeloma Patients Following Standard Versus High-Dose Chemotherapy and Autologous Stem Cell Transplantation |
| title_full_unstemmed | Sars-Cov-2 Vaccination Response Monitoring in Lymphoma and Multiple Myeloma Patients Following Standard Versus High-Dose Chemotherapy and Autologous Stem Cell Transplantation |
| title_short | Sars-Cov-2 Vaccination Response Monitoring in Lymphoma and Multiple Myeloma Patients Following Standard Versus High-Dose Chemotherapy and Autologous Stem Cell Transplantation |
| title_sort | sars-cov-2 vaccination response monitoring in lymphoma and multiple myeloma patients following standard versus high-dose chemotherapy and autologous stem cell transplantation |
| topic | Poster Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665176/ http://dx.doi.org/10.1182/blood-2022-166703 |
| work_keys_str_mv | AT markovicuros sarscov2vaccinationresponsemonitoringinlymphomaandmultiplemyelomapatientsfollowingstandardversushighdosechemotherapyandautologousstemcelltransplantation AT milonegiulioantonio sarscov2vaccinationresponsemonitoringinlymphomaandmultiplemyelomapatientsfollowingstandardversushighdosechemotherapyandautologousstemcelltransplantation AT carcodaniela sarscov2vaccinationresponsemonitoringinlymphomaandmultiplemyelomapatientsfollowingstandardversushighdosechemotherapyandautologousstemcelltransplantation AT iachellivaleria sarscov2vaccinationresponsemonitoringinlymphomaandmultiplemyelomapatientsfollowingstandardversushighdosechemotherapyandautologousstemcelltransplantation AT parrinellonunziatinalaura sarscov2vaccinationresponsemonitoringinlymphomaandmultiplemyelomapatientsfollowingstandardversushighdosechemotherapyandautologousstemcelltransplantation AT scirepaola sarscov2vaccinationresponsemonitoringinlymphomaandmultiplemyelomapatientsfollowingstandardversushighdosechemotherapyandautologousstemcelltransplantation AT amatogabriella sarscov2vaccinationresponsemonitoringinlymphomaandmultiplemyelomapatientsfollowingstandardversushighdosechemotherapyandautologousstemcelltransplantation AT galbofederica sarscov2vaccinationresponsemonitoringinlymphomaandmultiplemyelomapatientsfollowingstandardversushighdosechemotherapyandautologousstemcelltransplantation AT milonegiuseppe sarscov2vaccinationresponsemonitoringinlymphomaandmultiplemyelomapatientsfollowingstandardversushighdosechemotherapyandautologousstemcelltransplantation AT martoranaemanuele sarscov2vaccinationresponsemonitoringinlymphomaandmultiplemyelomapatientsfollowingstandardversushighdosechemotherapyandautologousstemcelltransplantation AT moschettigaetano sarscov2vaccinationresponsemonitoringinlymphomaandmultiplemyelomapatientsfollowingstandardversushighdosechemotherapyandautologousstemcelltransplantation |